Nicole DeFeudis - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Nicole DeFeudis's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Nicole DeFeudis
Verified
Editor and Reporter, Endpoints News
Massachusetts
Beats
Awe and Wonder, Understanding Grief Comforting People in Distress, LonelinessSocial Isolation, Building Community Life Transitions
Anything NOT pop culture related.
Content
Trump’s executive order on drug pricing; Pfizer drops oral obesity drug; Seed rounds at their lowest in years; and more
By Nicole DeFeudis Verified| Endpoints News Verified Happy Saturday and welcome back to Endpoints Weekly. It was a short week for us with Good Friday this week, but we’re still chock full …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
By Nicole DeFeudis Verified| Endpoints News Verified The UK on Thursday authorized GSK’s Blenrep to treat certain multiple myeloma patients in two different regimens, marking the drug’s first approval worldwide since it …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Leqembi wins EU authorization for some Alzheimer's patients, giving Biogen, Eisai a boost over Lilly
By Nicole DeFeudis Verified| Endpoints News Verified European regulators on Tuesday authorized the use of Biogen and Eisai’s Alzheimer’s treatment Leqembi for some early-stage patients “under strict conditions.” The decision from the … Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Company Info
Endpoints News
Endpoints News is an independent news organization dedicated to the biopharmaceutical industry. Founded in 2016 by Arsalan Arif and John Carroll, it has established itself as a trusted source of information, boasting over 163,000 subscribers, including executives and scientific leaders from top pharmaceutical companies and biotech startups worldwide. The organization provides daily news reports, analysis, and events tailored for biopharma professionals. Its offerings include daily newsletters like the Early Edition, investigative reporting on drug development and regulatory updates, and in-person and virtual conferences such as the Endpoints Summit. Endpoints News emphasizes independent journalism and operates on a subscription model, providing premium content to subscribers while maintaining ad-free reporting. With a focus on both scientific and business aspects of the industry, it serves decision-makers across the global pharmaceutical landscape.
Lawrence, Kansas, United States
+1 785-813-1733
Founded: 2014